Skip to main content

Advertisement

Log in

Patient-reported outcomes in ANCA-associated vasculitis. A comparison between Birmingham Vasculitis Activity Score and routine assessment of patient index data 3

  • Original Article
  • Published:
Clinical Rheumatology Aims and scope Submit manuscript

Abstract

The objective of this study was to determine health-related quality of life (HRQoL) in patients with ANCA-associated vasculitis (AAV) as measured by the “routine assessment of patient index data 3” (RAPID3) and whether RAPID3 is correlated with disease activity as determined by the Birmingham Vasculitis Activity Score (BVAS). Data from patients at an academic institution vasculitis clinic seen between Jan 2010 and Jan 2012 were collected using chart review. BVAS and RAPID3 scores were calculated at each patient visit. RAPID3 was compared between patients in remission (BVAS = 0) and patients with active disease (BVAS > =1) at all visits for four consecutive visits, when data available, at least 3 months apart during the period mentioned. Robust generalized estimating equations (GEE) in linear regression models evaluated associations between the RAPID3 and BVAS over all available observations, adjusting for intra-subject correlations. Thirty-four patients were included in the study, 26 had granulomatosis with polyangiitis (GPA), five microscopic polyangiitis (MPA), and three eosinophilic granulomatosis with polyangiitis (EGPA). Patients at first visit had impaired HRQoL as measured by RAPID3 [6.8 (3.1–12.6)]. The median RAPID3 scores were higher in patients with active disease as compared to patients in remission (7.0 vs. 3.0, p = 0.115; 8.8 vs. 1.0, p = 0.011; 6.1 vs. 2.0, p = 0.032; and 11.7 vs. 2.0, p = 0.128 for visits 1, 2, 3, and 4, respectively). In longitudinal GEE models incorporating all observations there was a strong association between the RAPID3 (per 1 unit) and BVAS (per 1 unit) [β 0.21 (0.10, 0.32) p < 0.001]. RAPID3 can be used to measure HRQoL in patients with AAV. RAPID3 correlated significantly with BVAS. RAPID3 can discriminate between disease states in AAV. This instrument may help document patient experience and add to clinical decisions.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Tomasson G, Boers M, Walsh M et al (2012) Assessment of health-related quality of life as an outcome measure in granulomatosis with polyangiitis (Wegener’s). Arthritis Care Res 64:273–279. doi:10.1002/acr.20649

    Article  Google Scholar 

  2. Brezinova P, Englbrecht M, Lovric S et al (2013) Coping strategies and depressiveness in primary systemic vasculitis—what is their impact on health-related quality of life? Rheumatology 52:1856–1864. doi:10.1093/rheumatology/ket237

    Article  PubMed  Google Scholar 

  3. Merkel PA, Herlyn K, Mahr AD et al (2009) Progress towards a core set of outcome measures in small-vessel vasculitis. Report from OMERACT 9. J Rheumatol 36:2362–2368. doi:10.3899/jrheum.090373

    Article  PubMed Central  PubMed  Google Scholar 

  4. Luqmani RA, Bacon PA, Moots RJ et al (1994) Birmingham Vasculitis Activity Score (BVAS) in systemic necrotizing vasculitis. QJM Mon J Assoc Physicians 87:671–678

    CAS  Google Scholar 

  5. Grayson PC, Amudala NA, Mcalear CA et al (2013) Illness perceptions and fatigue in systemic vasculitis. Arthritis Care Res 65:1835–1843. doi:10.1002/acr.22069

    Article  Google Scholar 

  6. Pincus T (2010) Are patient questionnaire scores as “scientific” as laboratory tests for rheumatology clinical care? Bull NYU Hosp Jt Dis 68:130–139

    PubMed  Google Scholar 

  7. Askanase AD, Castrejon I, Pincus T (2011) Quantitative data for care of patients with systemic lupus erythematosus in usual clinical settings: a patient multidimensional health assessment questionnaire and physician estimate of noninflammatory symptoms. J Rheumatol 38:1309–1316. doi:10.3899/jrheum.101091

    Article  PubMed  Google Scholar 

  8. Hoffman GS, Drucker Y, Cotch MF et al (1998) Wegener’s granulomatosis: patient-reported effects of disease on health, function, and income. Arthritis Rheum 41:2257–2262. doi:10.1002/1529-0131(199812)41:12<2257::AID-ART22>3.0.CO;2-K

    Article  CAS  PubMed  Google Scholar 

  9. Pincus T, Swearingen C, Wolfe F (1999) Toward a multidimensional health assessment questionnaire (MDHAQ): assessment of advanced activities of daily living and psychological status in the patient-friendly health assessment questionnaire format. Arthritis Rheum 42:2220–2230

    Article  CAS  PubMed  Google Scholar 

  10. Pincus T, Askanase AD, Swearingen CJ (2009) A multi-dimensional health assessment questionnaire (MDHAQ) and routine assessment of patient index data (RAPID3) scores are informative in patients with all rheumatic diseases. Rheum Dis Clin North Am 35:819–827. doi:10.1016/j.rdc.2009.10.017

    Article  PubMed  Google Scholar 

  11. Pincus T (2008) Pain, function, and RAPID scores: vital signs in chronic diseases, analogous to pulse and temperature in acute diseases and blood pressure and cholesterol in long-term health. Bull NYU Hosp Jt Dis 66:155–165

    PubMed  Google Scholar 

  12. Pincus T, Castrejon I (2011) MDHAQ/RAPID3 scores: quantitative patient history data in a standardized “scientific” format for optimal assessment of patient status and quality of care in rheumatic diseases. Bull NYU Hosp Jt Dis 69:201–214

    PubMed  Google Scholar 

  13. Suppiah R, Mukhtyar C, Flossmann O et al (2011) A cross-sectional study of the Birmingham Vasculitis Activity Score version 3 in systemic vasculitis. Rheumatol Oxf Engl 50:899–905. doi:10.1093/rheumatology/keq400

    Article  Google Scholar 

  14. Fries JF, Hunder GG, Bloch DA et al (1990) The American College of Rheumatology 1990 criteria for the classification of vasculitis. Summary. Arthritis Rheum 33:1135–1136

    Article  CAS  PubMed  Google Scholar 

  15. Jennette JC, Falk RJ, Andrassy K et al (1994) Nomenclature of systemic vasculitides. Proposal of an international consensus conference. Arthritis Rheum 37:187–192

    Article  CAS  PubMed  Google Scholar 

  16. Merkel PA (2012) Defining disease activity and damage in patients with small-vessel vasculitis. Cleve Clin J Med 79(Suppl 3):S11–S15. doi:10.3949/ccjm.79.s3.03

    Article  PubMed  Google Scholar 

  17. Cochran J, Conn VS (2008) Meta-analysis of quality of life outcomes following diabetes self-management training. Diabetes Educ 34:815–823. doi:10.1177/0145721708323640

    Article  PubMed Central  PubMed  Google Scholar 

  18. Koutantji M, Harrold E, Lane SE et al (2003) Investigation of quality of life, mood, pain, disability, and disease status in primary systemic vasculitis. Arthritis Rheum 49:826–837. doi:10.1002/art.11471

    Article  PubMed  Google Scholar 

Download references

Disclosure

None.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Antoine G. Sreih.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Annapureddy, N., Elsallabi, O., Baker, J. et al. Patient-reported outcomes in ANCA-associated vasculitis. A comparison between Birmingham Vasculitis Activity Score and routine assessment of patient index data 3. Clin Rheumatol 35, 395–400 (2016). https://doi.org/10.1007/s10067-015-2921-2

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10067-015-2921-2

Keywords

Navigation